The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.
Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
Open accessAbstract
Accumulating evidence indicates that obesity is closely associated with an increased risk of metabolic diseases such as insulin resistance, type 2 diabetes, dyslipidemia and nonalcoholic fatty liver disease. Obesity results from an imbalance between food intake and energy expenditure, which leads to an excessive accumulation of adipose tissue. Adipose tissue is now recognized not only as a main site of storage of excess energy derived from food intake but also as an endocrine organ. The expansion of adipose tissue produces a number of bioactive substances, known as adipocytokines or adipokines, which trigger chronic low-grade inflammation and interact with a range of processes in many different organs. Although the precise mechanisms are still unclear, dysregulated production or secretion of these adipokines caused by excess adipose tissue and adipose tissue dysfunction can contribute to the development of obesity-related metabolic diseases. In this review, we focus on the role of several adipokines associated with obesity and the potential impact on obesity-related metabolic diseases. Multiple lines evidence provides valuable insights into the roles of adipokines in the development of obesity and its metabolic complications. Further research is still required to fully understand the mechanisms underlying the metabolic actions of a few newly identified adipokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–278 of 278
Leptin Impairs Insulin Signaling in Rat Adipocytes
Pérez, C., Fernández‐Galaz, C., Fernández‐Agulló, T., Arribas, C., Andrés, A., Ros, M., & Carrascosa, J. M. (2004) · Diabetes · doi:10.2337/diabetes.53.2.347 · Cited by 148
Hodge-Dufour, J., Marino, M. W., Horton, M. R., Jungbluth, A., Burdick, M. D., Strieter, R. M., Noble, P. W., Hunter, C. A., & Puré, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13806 · Cited by 144
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Feinstein, S. B., Kondos, G. T., Pérez, A., & Mazzone, T. (2008) · Diabetes · doi:10.2337/db08-0157 · Cited by 142
Circulating visfatin level is correlated with inflammation, but not with insulin resistance
Oki, K., Yamane, K., Kamei, N., Nojima, H., & Kohno, N. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02966.x · Cited by 141
Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo
Schneider, J. G., von Eynatten, M., Schiekofer, S., Nawroth, P. P., & Dugi, K. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2181 · Cited by 141
Horowitz, J. F., & Klein, S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.6.e1144 · Cited by 138 · cited 1×
“Obese subjects had greater whole body free fatty acids rates of appearance in plasma compared with lean subjects [60], and a sustained reduction in plasma free fatty acids levels after treatment of lipolysis inhibitor was associated with an improvement of insulin sensitivity in diabetic obese subjects [61].”
BackgroundCho, S.-J., Jung, U. J., & Choi, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000347 · Cited by 136
Self-citationEL-Mesallamy, H. O., Kassem, D. H., El‐Demerdash, E., & Amin, A. I. (2010) · Metabolism · doi:10.1016/j.metabol.2010.04.008 · Cited by 135
Lipid metabolism in hepatic steatosis
Bradbury, M. W., & Berk, P. D. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.005 · Cited by 135
Lipolysis in human adipocytes, effects of cell size, age and of regional differences.
Engfeldt, P., & Arner, P. (1988) · PubMed · Cited by 135
Carr, M. C., Hokanson, J. E., Zambon, A., Deeb, S. S., Barrett, P. H. R., Purnell, J. Q., & Brunzell, J. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.6.7586 · Cited by 130
Öst, A., Danielsson, A., Lidén, M., Eriksson, U., Nyström, F. H., & Strålfors, P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8173com · Cited by 127
Hu, W., Li, L., Yang, M., Luo, X., Ran, W., Liu, D., Xiong, Z., Liu, H., & Yang, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2466 · Cited by 127
Adipose tissue gene expression of factors related to lipid processing in obesity
Clemente-Postigo, M., Queipo-Ortuño, M. I., Fernandez-Garcia, D., Gomez-Huelgas, R., Tinahones, F. J., & Cardona, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024783 · Cited by 124
Simeoni, E., Hoffmann, M. M., Winkelmann, B. R., Ruiz, J., Fleury, S., Boehm, B. O., M�rz, W., & Vassalli, G. (2004) · Diabetologia · doi:10.1007/s00125-004-1494-4 · Cited by 124
Kielstein, J. T., Becker, B., Graef, S., Brabant, G. E., Haller, H. G., & Fliser, D. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00409-8 · Cited by 124
Contois, J. H., Warnick, G. R., & Sniderman, A. D. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.05.004 · Cited by 123
Adiponectin, hepatocellular dysfunction and insulin sensitivity
López‐Bermejo, A., Botas, P., Funahashi, T., Delgado, E., Kihara, S., Ricart, W., & Fernández‐Real, J. M. (2004) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2004.01977.x · Cited by 121
Ruan, X. Z., Varghese, Z., Powis, S. H., & Moorhead, J. F. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00025.x · Cited by 115
Munkhtulga, L., Nakayama, K., Utsumi, N., Yanagisawa, Y., Gotoh, T., Omi, T., Kumada, M., Erdenebulgan, B., Zolzaya, K., Lkhagvasuren, T., et al. (2006) · Human Genetics · doi:10.1007/s00439-006-0264-4 · Cited by 113
Targher, G., Bertolini, L., Scala, L., Poli, F., Zenari, L., & Falezza, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02151.x · Cited by 110
Wascher, T. C., Lindeman, J. H. N., Sourij, H., Kooistra, T., Pacini, G., & Roden, M. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00221 · Cited by 109
Rizzo, M., Pernice, V., Frasheri, A., Lorenzo, G. D., Rini, G. B., Spinas, G. A., & Berneis, K. K. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03407.x · Cited by 107
Wood, I. S., Wang, B., Jenkins, J. R., & Trayhurn, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.068 · Cited by 106
Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese
Dixon, J. B., Bhathal, P. S., Jonsson, J. R., Dixon, A. F. R., Powell, E. E., & O’Brien, P. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00459-8 · Cited by 101
Leptin and liver fibrosis: A matter of fat
Marra, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33369 · Cited by 100
Chang, Y., Chang, T., Lee, W., & Chuang, L. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.011 · Cited by 98
Adiponectin deficiency suppresses ABCA1 expression and ApoA‐I synthesis in the liver
Oku, H., Matsuura, F., Koseki, M., Sandoval, J. C., Yuasa‐Kawase, M., Tsubakio‐Yamamoto, K., Masuda, D., Maeda, N., Ohama, T., Ishigami, M., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.038 · Cited by 97
Discordant regulation of proteins of cholesterol metabolism during the acute phase response
Kr, F., Pollock, A. S., Moser, A. H., Shigenaga, J. K., & Grünfeld, C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39734-0 · Cited by 90
Serum amyloid A: The “other” inflammatory protein
O’Brien, K. D., & Chait, A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0066-0 · Cited by 87
Impaired insulin action in subcutaneous adipocytes from women with visceral obesity
Johnson, J. A., Fried, S. K., Pi-Sunyer, X., & Albu, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.1.e40 · Cited by 87
Harðardóttir, I., Moser, A. H., Memon, R. A., Grünfeld, C., & Feingold, K. R. (1994) · PubMed · Cited by 86
Hu, Z.-P., Deng, H., & Qu, H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.026 · Cited by 86
Parks, E. J., & Hellerstein, M. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600018-jlr200 · Cited by 85
Harðardóttir, I., Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80798-3 · Cited by 82
Regulation of plasma fatty acid metabolism
Saleh, J., Sniderman, A. D., & Cianflone, K. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00099-6 · Cited by 81
Ettinger, W., Miller, L. D., Albers, J., Smith, T. K., & Parks, J. S. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42750-6 · Cited by 79
Angiopoietin-Like Protein 2 and Risk of Type 2 Diabetes in a General Japanese Population
Doi, Y., Ninomiya, T., Hirakawa, Y., Takahashi, O., Mukai, N., Hata, J., Iwase, M., Kitazono, T., Oike, Y., & Kiyohara, Y. (2012) · Diabetes Care · doi:10.2337/dc12-0166 · Cited by 77
Qin, B., Anderson, R. A., & Adeli, K. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00407.2007 · Cited by 75
Interleukin-6 stimulates lipolysis in porcine adipocytes
Yang, Y., Ju, D., MingTao, Z., & Yang, G. (2008) · Endocrine · doi:10.1007/s12020-008-9085-7 · Cited by 72
Sfrp5 correlates with insulin resistance and oxidative stress
Carstensen, M., Herder, C., Kempf, K., Erlund, I., Martin, S., Köenig, W., Sundvall, J., Bidel, S., Kuha, S., Roden, M., et al. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12052 · Cited by 65
Ülgen, F., Herder, C., Kühn, M. C., Willenberg, H. S., Schott, M., Scherbaum, W. A., & Schinner, S. (2010) · Archives of Physiology and Biochemistry · doi:10.3109/13813451003631421 · Cited by 58
Nair, A. K., Sugunan, D., Kumar, H., & Gopalakrishnapillai, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011444 · Cited by 58
Grünfeld, C., Dinarello, C. A., & Feingold, K. R. (1991) · Metabolism · doi:10.1016/0026-0495(91)90062-2 · Cited by 57
Resistin: a new link between obesity and insulin resistance?
Vidal‐Puig, A., & O’Rahilly, S. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01377.x · Cited by 57
Regulatory SNP in the RBP4 Gene Modified the Expression in Adipocytes and Associated With BMI
Munkhtulga, L., Nagashima, S., Nakayama, K., Utsumi, N., Yanagisawa, Y., Gotoh, T., Omi, T., Kumada, M., Zolzaya, K., Lkhagvasuren, T., et al. (2009) · Obesity · doi:10.1038/oby.2009.358 · Cited by 56
Mohrschladt, M. F., Weverling‐Rijnsburger, A. W. E., de Man, F. H. A. F., Stoeken, D.-J., Sturk, A., Smelt, A. H. M., & Westendorp, R. G. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00316-0 · Cited by 54
Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases
Illei, G. G., & Lipsky, P. E. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00167-9 · Cited by 54
The blind men 'see' the elephant-the many faces of fatty liver disease
Girija, S. M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.831 · Cited by 53
Homma, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.265 · Cited by 52
Charles, M.-A. A., Fontbonne, A., Thibult, N., Claude, J., Warnet, J., Rosselin, G., Ducimetière, P., & Eschwège, É. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.3.292 · Cited by 52
Exploring the activated adipogenic niche: Interactions of macrophages and adipocyte progenitors
Lee, Y., Thacker, R. I., Hall, B. K., Kong, R., & Granneman, J. G. (2014) · Cell Cycle · doi:10.4161/cc.27647 · Cited by 51
Xu, X., Wang, H., Wang, Z., & Xiao, W. L. (2009) · Experimental Lung Research · doi:10.3109/01902140902912519 · Cited by 51
Cytokines regulation of low-density lipoprotein receptor gene transcription in human mesangial cells
Ruan, X. Z., Varghese, Z., Fernando, R., & Moorhead, J. F. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.6.1391 · Cited by 51
Sultan, A., Strodthoff, D., Robertson, A.-K. L., Paulsson‐Berne, G., Fauconnier, J., Parini, P., Rydén, M., Thierry‐Mieg, N., Johansson, M. E., Chibalin, A., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.190280 · Cited by 50
Serum amyloid A3 expression is stimulated by dexamethasone and interleukin-6 in 3T3-L1 adipocytes
Faßhauer, M., Klein, J. C., Kralisch, S., Klier, M., Lössner, U., Blüher, M., & Paschke, R. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05699 · Cited by 49
Fernández‐Real, J. M., Gutiérrez, C., Ricart, W., Castiñeira, M.-J., Vendrell, J. J., & Richart, C. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00156-2 · Cited by 45
Tan, H., Liu, X., Bi, X., Xing, S., Li, L., Gong, H., Zhong, M., Wang, Z., Zhang, Y., & Zhang, W. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.053 · Cited by 44
Ruan, X. Z., Moorhead, J. F., Fernando, R. L., Wheeler, D. C., Powis, S. H., & Varghese, Z. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320088 · Cited by 43
Klop, B., Jukema, J. W., Rabelink, T. J., & Cabezas, M. C. (2012) · PubMed · Cited by 42
Biochemical and Physical Properties of Remnant-HDL2 and of Preβ1-HDL Produced by Hepatic Lipase
Guendouzi, K., Jaspard‐Vinassa, B., Barbaras, R., Motta, C., Vieu, C., Marcel, Y. L., Chap, H., Perret, B., & Collet, X. (1999) · Biochemistry · doi:10.1021/bi9815086 · Cited by 41
Zietz, B., Büchler, C., Herfarth, H. H., et al. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00436.x · Cited by 40
Interleukin-1 effect on glycemia in the non-obese diabetic mouse at the pre-diabetic stage.
Amrani, A., Jafarian-Tehrani, M., Morméde, P., Durant, S., Pléau, J., Haour, F., Dardenne, M., & Homo-Delarche, F. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1480139 · Cited by 40
Byrne, C. D., Maison, P., Halsall, D. J., Martensz, N. D., Hales, C. N., & Wareham, N. J. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00184.x · Cited by 37
Regional specificity of ASP binding in human adipose tissue.
Saleh, J., Christou, N., & Cianflone, K. (1999) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e815 · Cited by 35
Human RBP4 adipose tissue expression is gender specific and influenced by leptin
Kos, K., Wong, S., Tan, B. K., Kerrigan, D. D., Randeva, H. S., Pinkney, J. H., & Wilding, J. P. H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03892.x · Cited by 34
Serum Amyloid A Protein Regulates the Expression of Porcine Genes Related to Lipid Metabolism3
Chen, C. H., Wang, P. H., Liu, B. H., Hsu, H. H., Mersmann, H. J., & Ding, S. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.674 · Cited by 33
Ettinger, W. H., Miller, L. A., Smith, T. K., & Parks, J. S. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90306-g · Cited by 32
Hyperlipidaemias and serum cytokines in patients with coronary artery disease
Mizia‐Stec, K., Zahorska‐Markiewicz, B., Mandecki, T., Janowska, J., SZULC, A., Jastrzebska-Maj, E., & Gąsior, Z. (2003) · Acta Cardiologica · doi:10.2143/ac.58.1.2005253 · Cited by 32
Reeds, D. N., Stuart, C. A., Perez, O., & Klein, S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.006 · Cited by 30
Kim, D. S., Kang, S., Moon, N. R., & Park, S. (2013) · Cytokine · doi:10.1016/j.cyto.2013.11.008 · Cited by 30
Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver
Serin, E., Özer, B., G�m�rd�l�, Y., Kayaselçuk, F., Kul, K., & Boyacıoğlu, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1084-5 · Cited by 23
Jing, Y., Zhu, D., Bi, Y., et al. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.030 · Cited by 20
Bartolomé, N., RODRÍGUEZ, L., Martínez, M. J., Ochoa, B., & Chico, Y. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.070 · Cited by 18
Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
Chang, C.-Y., Chen, M., Yang, W., Yeh, C., Ho, H., Chen, S., & Yang, Y. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.09.014 · Cited by 17
Poordad, F. F. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200411000-00002 · Cited by 16
Influence of heredity for obesity on adipocyte lipolysis in lean and obese subjects
Hellström, L., & Reynisdottir, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801134 · Cited by 14
Sáez, Y., Vacas, M., Santos, M. D. L., de Lafuente, J. P. S., Sagastagoitia, J. D., Molinero, E., & Iriarte, J. A. (2012) · ISRN Vascular Medicine · doi:10.5402/2012/451730 · Cited by 7
Cited by
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“In addition to these proinflammatory changes, adipocyte hypertrophy is associated with larger triglyceride stores, a higher lipolytic rate, and an atherogenic lipid profile: elevated concentrations of small dense low-density lipoprotein cholesterol, high concentrations of triglycerides, triglyceriderich remnants, very…”
BackgroundInfluentialAL-Ishaq, R. K., Abotaleb, M., Kubatka, P., Kajo, K., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9090430 · Cited by 741
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Antidiabetic Properties of Dietary Flavonoids: A Cellular Mechanism Review
Vinayagam, R., & Xu, B. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0057-7 · Cited by 597
Metabolic barriers to cancer immunotherapy
DePeaux, K., & Delgoffe, G. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00541-y · Cited by 597
Metadata
- Authors
- Jung, U., & Choi, M.-S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2014-04-11
- Volume
- 15
- Issue
- 4
- Pages
- 6184-6223
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W1978804351
- Cited by
- 1,880
- References
- 278
- FWCI
- 80.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.